CAS RN 1009119-64-5
Daclatasvir, TRC
CAS: 1009119-64-5 Fórmula molecular: C40 H50 N8 O6 Peso molecular (g/mol): 738.88 Sinónimo: Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester,BMS 790052,Daclatasvir,Daklinza,EBP 883 Nombre IUPAC: metilo N-[(2S)-1-[(2S)-2-[4-[4-[4-[4-[2-[(2S)-1-[(2S)-2-(metoxicarbonilamino)-3-metilbutanoil]pirrolidina-2-il]-1H-imidazol-4-il]fenil]-1H-imidazol-2-il]pirrolidina-1-il]-3-metil-1-oxobutan-2-il]carbamato SMILES: COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c2nc(c[nH]2)c3ccc(cc3)c4ccc(cc4)c5c[nH]c(n5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C
Daclatasvir, MedChemExpress
MedChemExpress Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 μM and 3.27 μM, respectively.